Cellestia is led by a Senior Management team with a proven track record in discovery and research, drug and business development, regulatory affairs, marketing and finance. Our Board of Directors has decades of experience in research, development as well as in founding, building and managing leading global life sciences companies. The management team is supported by an experienced network of advisors, all of whom have a profound and specific know-how that is relevant for the further development of Cellestia.
Advisors
Prof. Douglas Hanahan
Director of the Swiss Institute for Experimental Cancer Research
EPFL
Prof. Jon Aster
Prof. of Pathology and Chief of the Division of Hematopathology
Brigham and Women's Hospital and Harvard Medical School
Prof. Rhett Kovall
Assoc. Prof. University of Cincinnati College of Medicine
Dept. of Molecular Genetics, Biochemistry and Microbiology
Dr. Renata Ferrarotto
Assoc. Prof. & Director of the Head and Neck Clinical Research Program
MD Anderson Cancer Center, Houston
